Global Companion Animal Postoperative Pain Management Therapeutics Market by Animal Type (Feline, Canine), by Product (Anesthetics, NSAIDs) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global companion animal postoperative pain management therapeutics market was valued at USD 228,90 million in 2018. It is forecast to grow 6.7% over the forecast period. Postoperative pain relief is in high demand due to the increase in pet surgery, particularly orthopedic and dental. Dental surgeries will be more in demand due to the rising incidence of periodontal disease. The AMA report states that clinic visits for dogs rose by 6% between 2014 and 2017, owing to an increase in dental problems. Increasing companion animal ownership is expected to drive further revenue growth.

The market will be further fueled by rising disposable income in both developing and industrialized countries. According to the American Veterinary Medical Association's (AVMA) report, U.S. pet owners spent USD 15.42 billion on veterinary surgery in 2017. In 2017, around 20 million dogs underwent surgery. Among them, 5 million experienced post-operative pain.

The market for companion animal pain management therapeutics is expected to grow because of the increased adoption of NSAIDs following the restriction of opioids' use to manage postoperative pain. The demand for companion pain-relieving drugs is expected to rise due to increased concerns from pet owners and decreased use of off-label human opioids. Industry players are developing these drugs to address the unmet demand for local anesthetics that work long-lastingly for small animals. In situ Biologics' AniGelSR has demonstrated 72-hour efficacy during a preclinical study to manage post-operative pain. The FDA has yet to approve the drug, which will increase the market revenue over the next few years.

According to the Animal Cancer Foundation in 2017, the United States had approximately 65 million dogs and 32 millions cats. The growing number of pet clinics and veterinary hospitals is fueling the market for companion animal pain management therapeutics. The American Veterinary Medical Association's (AVMA) report states that the U.S. private practice for small animals increased 14% in 2018.

There are strict regulations regarding the use of opioids in animals and humans. This makes it less popular as a post-operative pain reliever. Around 40% of U.S. veterinarians prescribed opioids to animals for perioperative care in 2014. The U.S. FDA issued guidelines in 2017 regarding safe opioid use in pets. These guidelines require that veterinarians be licensed by Drug Enforcement to prescribe opioids to pets. A survey done by AVMA found that 44% of opioids had been misused or abused in 2018. 11% of pet owners were also intentionally hurting their pets to obtain opioids. These factors will likely limit the growth in opioids and increase revenue for postoperative pain relief drugs in the near future.

Product Insights

Due to their easy availability, the NSAIDs market dominated 2018 with a 45.0% revenue share. These drugs are used to control inflammation and pain following surgery. NSAIDs are much less expensive than opioids and anesthetics, which helps to increase its revenues. Previcox, Metacam, Deramaxx and Rimadyl (injectable) are some of the most popular NSAIDs used for post-operative pain management. Market players are working to create innovative NSAIDs that can be used for peri-operative pain management. Elanco was approved for Onsior in May 2016 for the treatment of pain after soft tissue surgery in dogs.

Over the forecast period, steady growth is expected in the anesthetics market. Lidocaine, bupivacaine, and other anesthetics are used frequently. An AVMA report shows that around 5 million dogs experienced post-operative pain in 2016. As pet owners want to bring their pets home following surgery, the demand for long-acting or control-release local anesthetics is growing. Nocita, a post-operative pain medication that can control pain for up 72 hours, was launched by Aratana Therapeutics in 2016.

Information on Animal Types

Due to an increase in surgeries, canines accounted for the largest share of the market in 2018. One of the key growth drivers is the rise in chronic diseases in dogs. The most common surgeries on dogs include dental, hip dysplasia and cataract surgery. All of these surgeries require ongoing care. The growth is expected to be further accelerated by the increasing adoption of dogs in households both in developing and developed countries.

Over the forecast period, the feline market is expected to grow at a steady rate. This steady growth can be attributed primarily to cat owners' increasing concerns about post-operative pain management for their cats. Another major driver of growth is the increase in cat surgeries. UTI, bladder stones, kidney disease, eye and dental problems, as well as ear infections, are the most common ailments in cats. The growth of cat adoptions in Europe and Asia is accelerating. In 2018, for example, the European feline population was 102.69 millions while the European canine population was only 84.91million. It is expected that favorable insurance policies will further increase the growth of this segment.

Regional Insights

In 2018, North America held the largest revenue share. The region's favorable healthcare system and rising government initiatives are expected to drive growth. The region is expected to see an increase in pet ownership and a growing demand for quality animal care. This will create revenue generation opportunities. The demand for pain management therapies for companion animals will rise due to the rising incidence of chronic diseases in pets. The market is also experiencing a rise in the number of veterinary procedures, particularly orthopedic and dental. According to the APPA report in 2018, Americans spent approximately USD 18.11 billion on veterinary services. This is due to the presence of industry giants such as Merck, Elanco and Zoetis boosting regional growth.

The availability of better treatments for companion animals is also a result of pet insurance's increasing demand. A report by the North American Pet Health Insurance Association, (NAPHIA) states that more than 2 million pets were insure in the U.S. and Canada in 2017. This represents an average increase of almost 17% over the previous year.

Over the forecasted time, Asia Pacific will experience a lucrative CAGR. The increasing prevalence of chronic diseases has resulted in an increase of companion animal surgeries. The market is expected to grow due to increasing pet ownership in Japan and China. According to the National Bureau of Statistics of China (NBS), China ranked third worldwide in dog ownership in 2017 with 27.4million pet dogs, just behind the United States (55.3 million) or Brazil (35.7 million). High demand for insurance policies further drives revenue generation in the region. According to the 2018 Pet Industry White Paper, Japan's pet owners spend approximately USD 740 per pet.

Market Share insights for Companion Animal Postoperative pain Management Therapeutics

This market is fragmented and marked by both small and large companies. Norbrook, Bayer AG and Elanco are the major market players. To increase market share, the companies are involved in strategic initiatives such as regional expansions. New product launches. Collaborations. Mergers and acquisitions.

Elanco purchased Aratana Therapeutics in April 2019 to increase its product range in pain management for companion animals. Ceva Polchem, a global hub for innovation in companion animal health, consolidated its Laval, France business in June 2019. This will increase the company's R&D capabilities on the market.

Companion Animal Postoperative pain Management Therapeutics Market Report Scope

The Report Covers Certain Segments

This report predicts revenue growth at the global, regional and country level and offers an analysis of industry trends in each sub-segment from 2014 to 2026. Grand View Research has divided the global companion animal postoperative pain relief therapeutics market report by product, region, and animal type.

• Product Outlook (Revenue USD Million, 2014-2026)

  • NSAIDs

  • Anesthetics

  • Opioids

  • Other

• The Animal Type Outlook (Revenue USD Million, 2014-2026)

  • Canine

  • Feline

• Regional Outlook (Revenue USD Million, 2014-2026)

  • North America

    • The U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

These are the most frequently asked questions about this report

b. Global companion animal postoperative pain management therapeutics market was valued at USD 242.07 Million in 2019. It is projected to grow to USD 256.59 Million in 2020.

b. Global companion animal postoperative pain management therapeutics market will grow at 6.7% compound annual growth rate from 2019 to 2026, to reach USD 382.36 millions by 2026.

b. With a 32.20% share in 2019, North America dominated companion animal postoperative pain management therapeutics. This can be attributed to increasing pet ownership and increased demand for quality animal care.

b. Some of the key players in the companion animal postoperative pain relief therapeutics market are Zoetis and Bayer AG. Elanco, Ceva, Norbrook, and Ceva.

b. b.

Up Market Research published a new report titled “Companion Animal Postoperative Pain Management Therapeutics Market research report which is segmented by Animal Type (Feline, Canine), by Product (Anesthetics, NSAIDs), By Players/Companies Bayer AG, Elanco, Ceva, Norbrook, Zoetis”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Companion Animal Postoperative Pain Management Therapeutics Market Report Segments:

The market is segmented by Animal Type (Feline, Canine), by Product (Anesthetics, NSAIDs).

Companion Animal Postoperative Pain Management Therapeutics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Companion Animal Postoperative Pain Management Therapeutics Market

Overview of the regional outlook of the Companion Animal Postoperative Pain Management Therapeutics Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Companion Animal Postoperative Pain Management Therapeutics Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Companion Animal Postoperative Pain Management Therapeutics Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Feline

                2. Canine

                1. Anesthetics

                2. NSAIDs

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Companion Animal Postoperative Pain Management Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Companion Animal Postoperative Pain Management Therapeutics Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.